======= PLEKHM2 =======
== Gene Information ==
* **Official Symbol**: PLEKHM2
* **Official Name**: pleckstrin homology and RUN domain containing M2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23207|23207]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q8IWE5|Q8IWE5]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=PLEKHM2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PLEKHM2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/609613|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a protein that binds the plus-end directed microtubule motor protein kinesin, together with the lysosomal GTPase Arl8, and is required for lysosomes to distribute away from the microtubule-organizing center. The encoded protein belongs to the multisubunit BLOC-one-related complex that regulates lysosome positioning. It binds a Salmonella effector protein called Salmonella induced filament A and is a critical host determinant in Salmonella pathogenesis. It has a domain architecture consisting of an N-terminal RPIP8, UNC-14, and NESCA (RUN) domain that binds kinesin-1 as well as the lysosomal GTPase Arl8, and a C-terminal pleckstrin homology domain that binds the Salmonella induced filament A effector protein. Naturally occurring mutations in this gene lead to abnormal localization of lysosomes, impaired autophagy flux and are associated with recessive dilated cardiomyopathy and left ventricular noncompaction. [provided by RefSeq, Feb 2017].
* **UniProt Summary**: N/A
|RUN|
|PH|
|positive regulation of membrane tubulation|
|regulation of membrane tubulation|
|regulation of plasma membrane organization|
|kinesin binding|
|lysosome localization|
|Golgi organization|
|endosome membrane|
|endomembrane system organization|
|organelle localization|
|regulation of protein localization|
|positive regulation of cellular component organization|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp77|Prochlorperazine 5.2μM R02 exp77]]|-1.9|
|[[:results:exp425|Beta-Estradiol 0.55μM R07 exp425]]|-1.72|
|[[:results:exp359|FK-506 30μM R07 exp359]]|-1.72|
|[[:results:exp259|6-Thio-2-deoxyguanosine 2μM R06 exp259]]|-1.71|
|[[:results:exp223|Cabazitaxel 0.001μM R05 exp223]]|-1.7|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 1/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|1/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 9557
* **Expression level (log2 read counts)**: 5.96
{{:chemogenomics:nalm6 dist.png?nolink |}}